|
Delayed
NSE India S.E.
05:59:23 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 228.06 INR | +0.55% |
|
+1.01% | +18.44% |
| Market Cap | 14.95B 156M 136M 128M 117M 219M 219M 1.54B 592M 7.62B 586M 573M 24.58B | P/E 2025 |
26.4x | P/E 2026 | 29.1x |
|---|---|---|---|---|---|
| Enterprise Value | 13.98B 146M 127M 120M 109M 205M 205M 1.43B 553M 7.12B 548M 536M 22.98B | EV / Sales 2025 |
4.92x | EV / Sales 2026 | 3.95x |
| Free-Float |
23.94% | Yield 2025 |
1.15% | Yield 2026 | 1.36% |
NSE India S.E.INR
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| JAGSNPHARM | Delayed | |
Bombay S.E.
| JAGSNPHARM | Delayed |
| 30/08/22 | Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme | PU |
| 16/08/22 | Jagsonpal Pharmaceuticals : Reply to Clarification Sought | PU |
| 16/07/22 | Jagsonpal Pharmaceuticals : Appointment | PU |
| 1 day | +0.58% | ||
| 1 week | +1.01% | ||
| Current month | -5.28% | ||
| 1 month | -5.25% | ||
| 3 months | +2.43% | ||
| 6 months | +25.24% | ||
| Current year | +18.44% |
| 1 week | 217.81 |  | 231.88 |
| 1 month | 217.81 | | 249.57 |
| Current year | 155 | | 264.5 |
| 1 year | 155 | | 264.5 |
| 3 years | 109.44 | | 328.04 |
| 5 years | 49.2 | | 328.04 |
| 10 years | 6.5 | | 328.04 |
| Manager | Title | Age | Since |
|---|---|---|---|
Manish Gupta
CEO | Chief Executive Officer | 59 | 15/07/2022 |
| Director of Finance/CFO | - | 06/10/2025 | |
Amrut Medhekar
COO | Chief Operating Officer | - | 03/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 03/12/2013 | |
Harsha Raghavan
CHM | Chairman | 54 | 15/07/2022 |
| Director/Board Member | - | 28/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.55% | +1.01% | -4.07% | +38.07% | 156M | |
| +1.04% | +2.34% | +54.91% | +111.75% | 1,038B | |
| -0.19% | +1.18% | +52.94% | +66.69% | 649B | |
| +0.20% | +1.04% | +18.88% | +72.38% | 467B | |
| +2.24% | +0.94% | +37.61% | +45.31% | 355B | |
| +0.90% | +1.95% | +18.79% | +25.27% | 269B | |
| +0.48% | +3.34% | +11.11% | +15.38% | 260B | |
| +1.95% | +3.06% | +37.75% | +45.93% | 213B | |
| -7.65% | -7.28% | -33.09% | -59.52% | 176B | |
| +0.30% | +2.83% | +31.97% | +100.03% | 187B | |
| Average | +0.08% | +0.68% | +22.68% | +46.13% | 361.53B | |
| Weighted average by Cap. | +0.60% | +1.47% | +35.87% | +65.83% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 2.69B 28.05M 24.46M 23.03M 20.98M 39.33M 39.38M 276M 106M 1.37B 105M 103M 4.42B | 2.87B 29.98M 26.14M 24.62M 22.42M 42.04M 42.09M 295M 114M 1.46B 113M 110M 4.72B |
| Net income | 554M 5.78M 5.04M 4.75M 4.32M 8.1M 8.11M 56.83M 21.9M 282M 21.71M 21.23M 910M | 431M 4.5M 3.92M 3.69M 3.36M 6.31M 6.31M 44.23M 17.05M 219M 16.89M 16.52M 708M |
| Net Debt | -1.19B -12.47M -10.88M -10.24M -9.33M -17.49M -17.51M -123M -47.28M -609M -46.85M -45.81M -1.96B | -976M -10.19M -8.89M -8.37M -7.62M -14.29M -14.31M -100M -38.63M -497M -38.28M -37.44M -1.61B |
Employees
1,297
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | ₹228.06 | +0.55% | 6,996 |
| 21/09/26 | ₹226.81 | -0.70% | 50,279 |
| 18/09/26 | ₹228.42 | +0.52% | 48,985 |
| 17/09/26 | ₹227.24 | -0.46% | 43,798 |
| 16/09/26 | ₹228.28 | +1.08% | 56,466 |
- Stock Market
- Stocks
- JAGSNPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
